The attractiveness and health corporation HydraFacial is going community by way of a merger with a exclusive objective acquisition corporation. In a statement, HyrdaFacial reported it has arrived at an agreement to merge with Vesper Healthcare Acquisition, a SPAC cofounded by the former main govt officer of Allergan, Brent Saunders.
The agreement offers HydraFacial an company value of $1.1 billion, consisting of $975 million payable on completion and $seventy five million right after specific acquisitions are done by the blended corporation. Subsequent the transaction, the corporation expects to have $one hundred million in funds and no debt.
The deal comes as U.S. funds markets have seen a surge of SPAC IPOs. The facts monitoring web-site SPAC Analytics reported there were 218 SPAC IPOs this year, accounting for forty eight% of overall U.S. IPO proceeds. Vesper filed for its IPO in September, four months right after AbbVie done its $63 billion acquisition of Allergan. At the time of its IPO, Vesper reported its major intention was to go after an original organization mix target in the pharmaceutical and health care industries, with specific aim on clinical aesthetics.
“This is a sizeable day for Vesper Healthcare and HydraFacial as we team up with a class-building corporation in the emerging space of attractiveness health,” Brent Saunders reported in a statement.
Subsequent the deal, HydraFacial’s main govt officer, Clint Carnell, will stay head of the corporation. Liyuan Woo will proceed as main money officer. Vesper CEO Brent Saunders will turn out to be govt chairman and Vesper’s CFO, Manisha Narasimhan, will turn out to be main method officer.
Institutional buyers including Fidelity Management & Exploration, Redmile Team, Principal Global Buyers, Camber Cash Management and Woodline Associates have dedicated $350 million. Linden Cash Associates will stay the premier shareholder.
The deal is expected to shut in the 1st 50 % of 2021.